fda 503a bulks list peptides bpc-157 Exciting news for coming out of today's committee hearing! The Pharmacy Compounding Advisory Committee voted 8-6 to recommend adding BPC- 157 to the for use in compounding for HIMS is up nearly 8%

HIMS is up nearly 8% after FDA advisers voted to recommend adding BPC 157 to the 503A Bulks List. A major win for the peptide market. peptidemedicine #fda #503a #compounding American Academy of Peptide Medicine A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline 83% of peptide aware Americans want the FDA to make peptides more accessible

SKU: 24378085066 · From lagence-mr.com